Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-25-059009 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 29, 2025 |
| Document Date | Dec 26, 2025 |
| Document | View SEC Filing |
Transactions
2
Total Shares
36,000
Total Value
$34,380.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Dec 26, 2025 | Exercise/Conversion | 18,000 | $1.91 | $34,380.00 | 117,713 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Dec 26, 2025 | Exercise/Conversion | 18,000 | $0.00 | $0.00 | 90,514 | Direct | โ | View Details |